GKOS · NYSE · Medical - Devices

Glaukos (GKOS)

Develops implantable glaucoma therapies and corneal cross-linking treatments.

$161.00
After-hours close+1.06 (+0.66%)
At close$159.94(−0.98%)
  1. GKOS Stock Surges 67% Year to Date: What's Driving the Rally?

    Zacks Investment ResearchMarket move